Filtros de búsqueda

Lista de obras de

(18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.

artículo científico publicado en 2013

A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

scientific article published on 04 November 2019

A clinically applicable method for the ex vivo generation of antigen-presenting cells from CD34+ progenitors

artículo científico publicado en 2000

A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

artículo científico publicado en 2015

A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma.

artículo científico publicado en 2012

A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM

artículo científico publicado en 2016

ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial

artículo científico publicado en 2020

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.

artículo científico publicado en 2015

Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups

artículo científico publicado en 2013

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure

artículo científico publicado en 2014

Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin Lymphoma.

artículo científico

Autologous stem cell transplantation remains beneficial for patients relapsing after R‐CHOP chemotherapy and who respond to salvage chemotherapy

artículo científico publicado el 16 de agosto de 2011

CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy

artículo científico publicado en 2020

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.

artículo científico publicado en 2018

CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas

artículo científico publicado en 2016

Cardiac tamponade in Hodgkin lymphoma.

artículo científico publicado en 2007

Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK.

artículo científico publicado en 2005

Central nervous system prophylaxis in patients with diffuse large B cell lymphoma, are we treating ourselves? A response to the recent BCSH Guideline - response to Griffin et al

artículo científico publicado en 2014

Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.

artículo científico publicado en 2017

Cerebrospinal fluid leak after bone marrow biopsy

artículo científico publicado en 2017

Ceroid accumulation by murine peritoneal macrophages exposed to artificial lipid-containing particles: the role of the hydrophilic component

artículo científico publicado en 1990

Clinical outcomes and risk factors for severe COVID-19 infection in patients with haematological disorders receiving chemo- or immunotherapy

artículo científico publicado en 2020

Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials

artículo científico publicado en 2018

Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma

artículo científico publicado en 2016

Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens

artículo científico publicado en 2005

Cutaneous reaction to pegfilgrastim presenting as severe generalized skin eruption.

artículo científico publicado en 2009

DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma

artículo científico publicado en 2019

Diffusion‐weighted MRI compared to FDG PET‐CT in the staging and response assessment of Hodgkin lymphoma

artículo científico publicado el 8 de diciembre de 2011

Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincr

artículo científico publicado el 22 de mayo de 2012

Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects

artículo científico publicado en 2004

FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study

artículo científico publicado en 2020

FLT PET-CT in evaluation of treatment response.

artículo científico

Facilities for the treatment of adults with haematological malignancies – 'Levels of Care': BCSH Haemato-Oncology Task Force 2009

scientific article published on 01 April 2010

False-Positive 18F-FDG PET/CT Imaging: Dramatic "Flare Response" After Rituximab Administration

artículo científico publicado en 2015

Favourable Outcomes for High-Risk Diffuse Large B-Cell Lymphoma (IPI 3-5) Treated with Front-Line R-CODOX-M/R-IVAC Chemotherapy: Results of a Phase 2 UK NCRI Trial

artículo científico publicado en 2020

Final Results of a Phase 1 Study of Loncastuximab Tesirine in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

artículo científico publicado en 2020

Follicular lymphoma involving the orbit

artículo científico publicado en 2007

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

artículo científico publicado en 2013

Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in Haematology

scientific article published on 27 August 2013

Guidelines for the first line management of classical Hodgkin lymphoma

artículo científico publicado en 2014

Haemophagocytic lymphohistiocytosis as a consequence of untreated B-cell chronic lymphocytic leukaemia

artículo científico publicado en 2017

Has Single-Agent Rituximab Replaced Watch-and-Wait for a Patient With Asymptomatic Low-Grade Follicular Lymphoma?

artículo científico publicado el 1 de septiembre de 2012

Hotel-based ambulatory care for complex cancer patients: a review of the University College London Hospital experience

artículo científico publicado el 13 de junio de 2012

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

artículo científico publicado en 2003

Lymph node core biopsies reliably permit diagnosis of lymphoproliferative diseases. Real-World Experience from 554 sequential core biopsies from a single centre

artículo científico publicado en 2020

Mini‐BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage‐refractory DLBCL

artículo científico publicado el 20 de marzo de 2012

Monocyte-derived dendritic cells do not proliferate and are not susceptible to retroviral transduction

artículo científico publicado en 2000

Neurolymphomatosis in a patient with lymphoblastic lymphoma

artículo científico publicado en 2012

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.

artículo científico publicado en 2016

Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab.

artículo científico publicado en 2018

Outcome for children after failed transplant for primary haemophagocytic lymphohistiocytosis

artículo científico publicado en 2001

Outcome of Elderly Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP: Results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial

artículo científico publicado en 2017

Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma

scientific article published on 23 April 2019

Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial

scientific article published on 20 May 2020

R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial

artículo científico publicado en 2019

Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection

artículo científico publicado en 2016

Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'

artículo científico publicado en 2020

Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma

artículo científico publicado en 2017

Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting

artículo científico

Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma

artículo científico publicado en 2016

Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%

artículo científico publicado en 2010

Rituximab maintenance in relapsed or refractory follicular non-Hodgkin's lymphoma: the evidence of its therapeutic value

artículo científico publicado el 30 de noviembre de 2007

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

artículo científico publicado en 2013

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

artículo científico publicado en 2014

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial

artículo científico publicado en 2016

Should we implement 'opt-out' HIV testing for patients with lymphoma?

artículo científico publicado en 2009

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

scientific article published on 14 February 2020

The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells

artículo científico publicado en 2000

The retinoblastoma family member, p107, is active in non-dividing monocyte-derived dendritic cells

scientific article published on 01 March 2001

The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to macrophage inflammatory protein 3beta and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathway

artículo científico publicado en 2002

Therapie einer Lymphknotentuberkulose

artículo científico publicado en 2010

Treatment for lymph node tuberculosis

scientific article published in the British Medical Journal

Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012)

scientific article published on 11 November 2019

Treatment of diffuse large B-cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS-penetrating R-IDARAM chemotherapy

artículo científico publicado en 2015

Update: the investigation and management of follicular lymphoma

artículo científico publicado en 2020

Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma

scientific article published on 31 October 2011

Whole Body 3.0 T Magnetic Resonance Imaging in Lymphomas: Comparison of Different Sequence Combinations for Staging Hodgkin's and Diffuse Large B Cell Lymphomas

artículo científico publicado en 2020